Jiyeon Oh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jiyeon Oh has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
- Dong Keon Yon
Department of Medicine Kyung Hee University College of Medicine Seoul South Korea
16 shared publications - Jaeyu Park
Center for Digital Health, Medical Science Research Institute Kyung Hee University Medical Center, Kyung Hee University College of Medicine Seoul South Korea
9 shared publications - Damiano Pizzol
Health Department, Eni Mozambique, Maputo, Mozambique
6 shared publications - Ho Geol Woo
Department of Medicine, Kyung Hee University College of Medicine, Seoul, South Korea
6 shared publications - Soeun Kim
Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, Korea
6 shared publications - Lee Smith
Centre for Health, Performance and Wellbeing Anglia Ruskin University Cambridge UK
5 shared publications
Latest Publications
- Open Access
- 2 October 2026
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 25 (10) , e71217
A Multimodal Multi‐task Model Integrating Scalp Imaging, Lipidomics, and Microbiome Data for Scalp Condition and Social Stigma: An Algorithm Development and Validation Study Across Multi‐ethnic Cohorts
- 2 October 2026
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 25 (10) , e71217
Open AccessA Multimodal Multi‐task Model Integrating Scalp Imaging, Lipidomics, and Microbiome Data for Scalp Condition and Social Stigma: An Algorithm Development and Validation Study Across Multi‐ethnic Cohorts
- Open Access
- 4 September 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (36) , e50516
National trends in the prevalence of depression and suicidal ideation stratified by academic achievement among adolescents, 2006 to 2022 in South Korea
Although severe depression and suicidal ideation among adolescents could be driven by excessive academic competition, research on this problem is still insufficient. Therefore, this study aims to analyze the relationship between academic achievement, depression, and suicidal ideation based on large-scale data. This study utilized data from the nationwide Korea Youth Risk Behavior Web-based Survey conducted from 2006 to 2022, investigating a total of 1,138,802 adolescents. Weighted proportions with 95% confidence intervals (CIs) and crude numbers and percentages were utilized to analyze and present the results in various formats. To accurately assess the association of academic achievement with depression and suicidal ideation, weighted odds ratios and their 95% CIs were calculated using weighted logistic regression analysis. Compared to students with high academic achievement, those with moderate achievement showed a 1.12 (95% CI = 1.11–1.13) times higher risk of depression, while those with low achievement had a 1.54 (1.52–1.56) times higher risk. Similarly, students with low academic achievement had a 1.49 (95% CI = 1.47–1.51) times higher risk of suicidal ideation. The prevalence of both depression and suicidal ideation decreased before the coronavirus disease 2019 pandemic but steadily increased during the pandemic. Females experienced higher rates of depression in each academic achievement group (high: weighted odds ratio = 1.49 [95% CI = 1.46–1.52]; middle: 1.59 [1.56–1.63]; low: 1.72 [1.69–1.75]) and suicidal ideation (high: 1.60 [1.57–1.64]; middle: 1.63 [1.59–1.68]; low: 1.82 [1.78–1.86]) than males. This study suggests that academic achievement can be associated with depression and suicidal ideation. Therefore, implementing mental health and educational programs targeting students with lower academic achievement may be crucial.
- 4 September 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (36) , e50516
Open AccessNational trends in the prevalence of depression and suicidal ideation stratified by academic achievement among adolescents, 2006 to 2022 in South Korea
Although severe depression and suicidal ideation among adolescents could be driven by excessive academic competition, research on this problem is still insufficient. Therefore, this study aims to analyze the relationship between academic achievement, depression, and suicidal ideation based on large-scale data. This study utilized data from the nationwide Korea Youth Risk Behavior Web-based Survey conducted from 2006 to 2022, investigating a total of 1,138,802 adolescents. Weighted proportions with 95% confidence intervals (CIs) and crude numbers and percentages were utilized to analyze and present the results in various formats. To accurately assess the association of academic achievement with depression and suicidal ideation, weighted odds ratios and their 95% CIs were calculated using weighted logistic regression analysis. Compared to students with high academic achievement, those with moderate achievement showed a 1.12 (95% CI = 1.11–1.13) times higher risk of depression, while those with low achievement had a 1.54 (1.52–1.56) times higher risk. Similarly, students with low academic achievement had a 1.49 (95% CI = 1.47–1.51) times higher risk of suicidal ideation. The prevalence of both depression and suicidal ideation decreased before the coronavirus disease 2019 pandemic but steadily increased during the pandemic. Females experienced higher rates of depression in each academic achievement group (high: weighted odds ratio = 1.49 [95% CI = 1.46–1.52]; middle: 1.59 [1.56–1.63]; low: 1.72 [1.69–1.75]) and suicidal ideation (high: 1.60 [1.57–1.64]; middle: 1.63 [1.59–1.68]; low: 1.82 [1.78–1.86]) than males. This study suggests that academic achievement can be associated with depression and suicidal ideation. Therefore, implementing mental health and educational programs targeting students with lower academic achievement may be crucial.
- Open Access
- 21 August 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (34) , e50327
Comparative burden of HIV and non-HIV sexually transmitted infections in Asia, 1990 to 2023
Sexually transmitted infections (STIs) remain an important public health challenge in Asia, yet comparative evidence assessing human immunodeficiency virus (HIV) and non-HIV STIs within a unified regional framework is limited. Using the Global Burden of Diseases, Injuries, and Risk Factors Study 2023 estimates, we assessed HIV and non-HIV STIs (including syphilis, chlamydia, gonorrhea, trichomoniasis, and genital herpes) across 5 Asian subregions (Central, East, South, and Southeast Asia, and high-income Asia Pacific) from 1990 to 2023. We quantified burden using age-standardized disability-adjusted life-year rates and prevalence rates, analyzed temporal trends using estimated annual percentage changes, and examined attributable risk factors including unsafe sex, childhood sexual abuse, drug use, and intimate partner violence. From 1990 to 2023, HIV burden increased across most Asian subregions, while non-HIV STIs generally declined. In 2023, Southeast Asia showed the highest HIV burden and the highest prevalence of non-HIV STIs. HIV exhibited regionally variable age peaks and a predominantly male burden, while non-HIV STIs were concentrated in earlier adulthood and showed discordant sex patterns, with higher prevalence in males but higher disability-adjusted life-year rates in females. Unsafe sex was the leading attributable risk factor across regions, except in Central Asia, where drug use predominated for HIV-attributable burden. These findings underscore the need for differentiated responses across Asia, including sustained HIV-case finding and treatment scale-up, targeted harm reduction, and strengthened STI surveillance and prevention in higher-burden settings.
- 21 August 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (34) , e50327
Open AccessComparative burden of HIV and non-HIV sexually transmitted infections in Asia, 1990 to 2023
Sexually transmitted infections (STIs) remain an important public health challenge in Asia, yet comparative evidence assessing human immunodeficiency virus (HIV) and non-HIV STIs within a unified regional framework is limited. Using the Global Burden of Diseases, Injuries, and Risk Factors Study 2023 estimates, we assessed HIV and non-HIV STIs (including syphilis, chlamydia, gonorrhea, trichomoniasis, and genital herpes) across 5 Asian subregions (Central, East, South, and Southeast Asia, and high-income Asia Pacific) from 1990 to 2023. We quantified burden using age-standardized disability-adjusted life-year rates and prevalence rates, analyzed temporal trends using estimated annual percentage changes, and examined attributable risk factors including unsafe sex, childhood sexual abuse, drug use, and intimate partner violence. From 1990 to 2023, HIV burden increased across most Asian subregions, while non-HIV STIs generally declined. In 2023, Southeast Asia showed the highest HIV burden and the highest prevalence of non-HIV STIs. HIV exhibited regionally variable age peaks and a predominantly male burden, while non-HIV STIs were concentrated in earlier adulthood and showed discordant sex patterns, with higher prevalence in males but higher disability-adjusted life-year rates in females. Unsafe sex was the leading attributable risk factor across regions, except in Central Asia, where drug use predominated for HIV-attributable burden. These findings underscore the need for differentiated responses across Asia, including sustained HIV-case finding and treatment scale-up, targeted harm reduction, and strengthened STI surveillance and prevention in higher-burden settings.
- Open Access
- 14 August 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (33) , e50207
Global, regional, and national burden of chronic kidney disease attributable to dietary risks, 1990 to 2021
Dietary risks are key modifiable contributors to chronic kidney disease (CKD) worldwide; however, their association with geographic or socioeconomic status remains underexplored. We aimed to quantify the global, regional, and national burden of CKD attributable to dietary risks from 1990 to 2021 using estimates from the Global Burden of Disease Study (GBD) 2021. Estimates of disability-adjusted life-years (DALYs) of CKD attributable to dietary risks were stratified by age, sex, location, and Socio-demographic Index (SDI) across 204 countries and territories from 1990 to 2021. We performed a comprehensive risk assessment for 7 dietary factors of CKD stratified by underlying causes: CKD due to type 2 diabetes mellitus (T2DM), hypertension, glomerulonephritis, and other unspecified causes. Every DALY estimate was accompanied by a 95% uncertainty interval. In 2021, the global age-standardized DALY rates of CKD attributable to dietary risks were 93.52 (95% uncertainty interval, 54.29–134.38) per 1,00,000. The leading dietary contributors were low fruit (38.68 [20.15–57.77] per 1,00,000) and vegetable (30.84 [14.80–50.20]) intake and high sodium (19.81 [2.51–54.57]) intake. The DALY rates increased sharply with age, with higher rates among males, reaching 920.46 in males and 840.16 in females at ages 95 years or above for low fruit intake. Low SDI regions showed a higher burden from CKD due to hypertension, attributable to fruit (54.23) and vegetable (55.99) deficiencies, while high SDI regions exhibited a greater burden from CKD due to T2DM, attributable to highly processed meat (11.36) and a relatively high burden from red meat (6.59) and sugar-sweetened beverages (4.01), with the greatest increase from high sugar-sweetened beverage intake (121.08%). The global burden of CKD attributable to dietary risk remains substantial, with persistent disparities in age, sex, location, and SDI. Targeted dietary strategies are needed to address these disparities and reduce the CKD burden worldwide.
- 14 August 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (33) , e50207
Open AccessGlobal, regional, and national burden of chronic kidney disease attributable to dietary risks, 1990 to 2021
Dietary risks are key modifiable contributors to chronic kidney disease (CKD) worldwide; however, their association with geographic or socioeconomic status remains underexplored. We aimed to quantify the global, regional, and national burden of CKD attributable to dietary risks from 1990 to 2021 using estimates from the Global Burden of Disease Study (GBD) 2021. Estimates of disability-adjusted life-years (DALYs) of CKD attributable to dietary risks were stratified by age, sex, location, and Socio-demographic Index (SDI) across 204 countries and territories from 1990 to 2021. We performed a comprehensive risk assessment for 7 dietary factors of CKD stratified by underlying causes: CKD due to type 2 diabetes mellitus (T2DM), hypertension, glomerulonephritis, and other unspecified causes. Every DALY estimate was accompanied by a 95% uncertainty interval. In 2021, the global age-standardized DALY rates of CKD attributable to dietary risks were 93.52 (95% uncertainty interval, 54.29–134.38) per 1,00,000. The leading dietary contributors were low fruit (38.68 [20.15–57.77] per 1,00,000) and vegetable (30.84 [14.80–50.20]) intake and high sodium (19.81 [2.51–54.57]) intake. The DALY rates increased sharply with age, with higher rates among males, reaching 920.46 in males and 840.16 in females at ages 95 years or above for low fruit intake. Low SDI regions showed a higher burden from CKD due to hypertension, attributable to fruit (54.23) and vegetable (55.99) deficiencies, while high SDI regions exhibited a greater burden from CKD due to T2DM, attributable to highly processed meat (11.36) and a relatively high burden from red meat (6.59) and sugar-sweetened beverages (4.01), with the greatest increase from high sugar-sweetened beverage intake (121.08%). The global burden of CKD attributable to dietary risk remains substantial, with persistent disparities in age, sex, location, and SDI. Targeted dietary strategies are needed to address these disparities and reduce the CKD burden worldwide.
- Open Access
- 19 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (51) , e45960
Cardiovascular risk across stages of cardiovascular-kidney-metabolic syndrome in South Korea, 2002–2022: A population-based cohort study
Cardiovascular-kidney-metabolic (CKM) syndrome is an emerging global framework, but evidence on stage-specific cardiovascular risks remains limited. Therefore, we investigated the association between CKM syndrome stages and cardiovascular outcomes, accounting for confounders and identifying the most influential components. This study utilized data from the Ansan – Ansung cohort, a longitudinal population-based cohort study conducted in South Korea from 2002 to 2022. CKM syndrome was classified according to the American Heart Association guidelines using the Predicting Risk of Cardiovascular Disease EVENTs equations into 4 stages: stage 0 (healthy), stage 1 (early risk), stage 2 (intermediate risk), and stage 3 (severe). A Cox proportional hazards model with time-varying covariates was applied to evaluate the associations between CKM syndrome stages and cardiovascular outcomes, including cerebrovascular disease, coronary artery disease, and myocardial infarction. Among the 9373 participants (47.2% male), 1074 (11.5%) were in stage 0, 1919 (20.5%) in stage 1, 3791 (40.5%) in stage 2, and 2589 (27.6%) in stage 3. Compared with stage 0, the risk of cardiovascular diseases was significantly increased in stage 2 (adjusted hazard ratio, 1.18 [95% confidence interval 1.03–1.38]) and stage 3 (1.26 [1.05–1.50]), whereas stage 1 showed no significant association. Among the underlying CKM conditions, hypertension exhibited the strongest association with all 3 outcomes: cerebrovascular disease (1.50 [1.34–1.67]), coronary artery disease (1.40 [1.22–1.60]), and myocardial infarction (1.43 [1.18–1.75]). Overall, this cohort study indicates that higher CKM syndrome stages are associated with increased cardiovascular risks. These findings underscore the importance of comprehensive, multidisciplinary strategies in clinical management and public health policies to reduce the burden of CKM syndrome and its related cardiovascular risks.
- 19 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (51) , e45960
Open AccessCardiovascular risk across stages of cardiovascular-kidney-metabolic syndrome in South Korea, 2002–2022: A population-based cohort study
Cardiovascular-kidney-metabolic (CKM) syndrome is an emerging global framework, but evidence on stage-specific cardiovascular risks remains limited. Therefore, we investigated the association between CKM syndrome stages and cardiovascular outcomes, accounting for confounders and identifying the most influential components. This study utilized data from the Ansan – Ansung cohort, a longitudinal population-based cohort study conducted in South Korea from 2002 to 2022. CKM syndrome was classified according to the American Heart Association guidelines using the Predicting Risk of Cardiovascular Disease EVENTs equations into 4 stages: stage 0 (healthy), stage 1 (early risk), stage 2 (intermediate risk), and stage 3 (severe). A Cox proportional hazards model with time-varying covariates was applied to evaluate the associations between CKM syndrome stages and cardiovascular outcomes, including cerebrovascular disease, coronary artery disease, and myocardial infarction. Among the 9373 participants (47.2% male), 1074 (11.5%) were in stage 0, 1919 (20.5%) in stage 1, 3791 (40.5%) in stage 2, and 2589 (27.6%) in stage 3. Compared with stage 0, the risk of cardiovascular diseases was significantly increased in stage 2 (adjusted hazard ratio, 1.18 [95% confidence interval 1.03–1.38]) and stage 3 (1.26 [1.05–1.50]), whereas stage 1 showed no significant association. Among the underlying CKM conditions, hypertension exhibited the strongest association with all 3 outcomes: cerebrovascular disease (1.50 [1.34–1.67]), coronary artery disease (1.40 [1.22–1.60]), and myocardial infarction (1.43 [1.18–1.75]). Overall, this cohort study indicates that higher CKM syndrome stages are associated with increased cardiovascular risks. These findings underscore the importance of comprehensive, multidisciplinary strategies in clinical management and public health policies to reduce the burden of CKM syndrome and its related cardiovascular risks.
- Open Access
- 24 October 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (43) , e45296
Trends in metabolic dysfunction-associated steatotic liver disease by household income, 2007–2022: A national representative study in South Korea
Metabolic dysfunction-associated steatotic liver disease (MASLD) could lead to liver-related life-threatening conditions. However, relatively little research has been conducted on trends in MASLD based on household income. This study aimed to examine trends in MASLD prevalence stratified by household income and identify socioeconomic factors associated with a risk of MASLD. Data from the Korea National Health and Nutrition Examination Survey from 2007 to 2022 were analyzed to examine MASLD prevalence among adults in South Korea, stratified by household income levels. Household income was categorized into quartiles, and covariates including sex, age, region of residence, education level, stress level, smoking status, and drinking status were assessed. Weighted prevalence estimates were calculated to assess trends in MASLD across the study period. In addition, logistic regression models were applied to estimate adjusted odds ratios with 95% confidence intervals (CIs), comparing pre-pandemic and pandemic periods as well as across income quartiles stratified by sex, age, and other covariates. A total of 70,276 individuals aged ≥19 years (male: 29,169 [41.51%]) from 2007 to 2022 were included in the analysis. MASLD prevalence increased over the study period across all household income levels. Particularly, in the medium-high and high household income levels, prevalence increased from 16.30% (95% CI, 14.83–17.76) in 2007 to 27.25% (95% CI, 24.46–30.04) in 2022 and from 15.15% (95% CI, 13.71–16.58) in 2007 to 25.44% (95% CI, 22.01–28.86) in 2022, respectively. The prevalence of MASLD exhibited a sex-specific trend, being higher among low-income females while tending to be higher among high-income males. Males, middle-aged individuals, high-stress levels, and smoking status were identified as risk factors for MASLD. This is the first study to analyze the trends of MASLD stratified by household income level in South Korea. These findings offer insights that may facilitate the identification of priority populations and guide the development of equity-focused public health strategies.
- 24 October 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (43) , e45296
Open AccessTrends in metabolic dysfunction-associated steatotic liver disease by household income, 2007–2022: A national representative study in South Korea
Metabolic dysfunction-associated steatotic liver disease (MASLD) could lead to liver-related life-threatening conditions. However, relatively little research has been conducted on trends in MASLD based on household income. This study aimed to examine trends in MASLD prevalence stratified by household income and identify socioeconomic factors associated with a risk of MASLD. Data from the Korea National Health and Nutrition Examination Survey from 2007 to 2022 were analyzed to examine MASLD prevalence among adults in South Korea, stratified by household income levels. Household income was categorized into quartiles, and covariates including sex, age, region of residence, education level, stress level, smoking status, and drinking status were assessed. Weighted prevalence estimates were calculated to assess trends in MASLD across the study period. In addition, logistic regression models were applied to estimate adjusted odds ratios with 95% confidence intervals (CIs), comparing pre-pandemic and pandemic periods as well as across income quartiles stratified by sex, age, and other covariates. A total of 70,276 individuals aged ≥19 years (male: 29,169 [41.51%]) from 2007 to 2022 were included in the analysis. MASLD prevalence increased over the study period across all household income levels. Particularly, in the medium-high and high household income levels, prevalence increased from 16.30% (95% CI, 14.83–17.76) in 2007 to 27.25% (95% CI, 24.46–30.04) in 2022 and from 15.15% (95% CI, 13.71–16.58) in 2007 to 25.44% (95% CI, 22.01–28.86) in 2022, respectively. The prevalence of MASLD exhibited a sex-specific trend, being higher among low-income females while tending to be higher among high-income males. Males, middle-aged individuals, high-stress levels, and smoking status were identified as risk factors for MASLD. This is the first study to analyze the trends of MASLD stratified by household income level in South Korea. These findings offer insights that may facilitate the identification of priority populations and guide the development of equity-focused public health strategies.
- Top Cited Papers
- 8 July 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 152 (1) , 11-23
Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Binational Population-Based Cohort Study
BACKGROUND: Despite the significant global impact of the COVID-19 pandemic, limited studies have investigated the long-term cardiovascular sequelae of SARS-CoV-2 infection, particularly among Asian populations. This large-scale, population-based binational cohort study with long-term follow-up aimed to investigate the association between SARS-CoV-2 infection and the risk of cardiovascular events. METHODS: We used binational, large-scale, and population-based cohorts, including a Korean nationwide cohort (K-CONV-N [Korea Disease Control and Prevention Agency-COVID-19-National Health Insurance Service cohort]; discovery cohort; n=18 989 129) and a Japanese nationwide cohort (Japan Medical Data Center; validation cohort; n=12 218 680). Individuals aged 20 years or older were included from January 1, 2020, to December 31, 2022. We assessed the long-term risk of incident cardiovascular outcomes after SARS-CoV-2 infection. The primary outcome was the risk of cardiovascular diseases based on International Classification of Diseases, Tenth Revision code diagnosis. After propensity score–based overlap weighting, Cox proportional hazard models were used to estimate adjusted hazard ratios for cardiovascular outcomes. We assessed the time attenuation effect of cardiovascular outcomes after SARS-CoV-2 infection. Multiple subgroup analyses were conducted by 16 cardiovascular outcomes, COVID-19 severity, vaccination, and SARS-CoV-2 strain. RESULTS: In the overlap-weighted discovery cohort, 7 960 357 individuals were included (mean age, 48.52 years [SD, 9.33]; men, 4 283 878 [53.82%]). SARS-CoV-2 infection was associated with a long-term increased risk of overall cardiovascular outcomes (adjusted hazard ratio, 1.62 [95% CI, 1.60–1.64]), particularly ischemic heart disease (1.81 [95% CI, 1.77–1.84]), heart failure (1.79 [95% CI, 1.73–1.85]), cerebrovascular disorders (1.65 [95% CI, 1.60–1.69]), major adverse cardiovascular events (1.65 [95% CI, 1.60–1.70]), inflammatory heart diseases (1.53 [95% CI, 1.31–1.80]), dysrhythmia (1.44 [95% CI, 1.42–1.46]), and thrombotic disorders (1.42 [95% CI, 1.35–1.48]). The increased risk persisted up to 18 months, with the highest association observed for 1 to 6 months after infection. The risk of cardiovascular diseases was pronounced with COVID-19 severity; however, it decreased with the administration of complete vaccination and subsequent booster doses. A similar risk of cardiovascular outcomes existed across every SARS-CoV-2 era (pre-delta, delta, and omicron). Similar patterns were observed in the validation cohort. The absolute risk of cardiovascular disease events after SARS-CoV-2 infection remained remarkably low (2.12% versus 1.31% in the noninfected population), particularly stroke (0.24% versus 0.13%) and ischemic heart disease (0.73% versus 0.39%). CONCLUSIONS: This binational study observed associations between SARS-CoV-2 infection and cardiovascular events during extended follow-up across viral eras. Complete vaccination was linked to lower cardiovascular events. However, the absolute risk of cardiovascular disease events after SARS-CoV-2 infection remained remarkably low, particularly for stroke and ischemic heart disease. Although these findings suggest ongoing vigilance and preventive measures remain crucial, they should be interpreted within the context of these low absolute risks when considering long-term cardiovascular complications.
- 8 July 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 152 (1) , 11-23
Top Cited PapersBurden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Binational Population-Based Cohort Study
BACKGROUND: Despite the significant global impact of the COVID-19 pandemic, limited studies have investigated the long-term cardiovascular sequelae of SARS-CoV-2 infection, particularly among Asian populations. This large-scale, population-based binational cohort study with long-term follow-up aimed to investigate the association between SARS-CoV-2 infection and the risk of cardiovascular events. METHODS: We used binational, large-scale, and population-based cohorts, including a Korean nationwide cohort (K-CONV-N [Korea Disease Control and Prevention Agency-COVID-19-National Health Insurance Service cohort]; discovery cohort; n=18 989 129) and a Japanese nationwide cohort (Japan Medical Data Center; validation cohort; n=12 218 680). Individuals aged 20 years or older were included from January 1, 2020, to December 31, 2022. We assessed the long-term risk of incident cardiovascular outcomes after SARS-CoV-2 infection. The primary outcome was the risk of cardiovascular diseases based on International Classification of Diseases, Tenth Revision code diagnosis. After propensity score–based overlap weighting, Cox proportional hazard models were used to estimate adjusted hazard ratios for cardiovascular outcomes. We assessed the time attenuation effect of cardiovascular outcomes after SARS-CoV-2 infection. Multiple subgroup analyses were conducted by 16 cardiovascular outcomes, COVID-19 severity, vaccination, and SARS-CoV-2 strain. RESULTS: In the overlap-weighted discovery cohort, 7 960 357 individuals were included (mean age, 48.52 years [SD, 9.33]; men, 4 283 878 [53.82%]). SARS-CoV-2 infection was associated with a long-term increased risk of overall cardiovascular outcomes (adjusted hazard ratio, 1.62 [95% CI, 1.60–1.64]), particularly ischemic heart disease (1.81 [95% CI, 1.77–1.84]), heart failure (1.79 [95% CI, 1.73–1.85]), cerebrovascular disorders (1.65 [95% CI, 1.60–1.69]), major adverse cardiovascular events (1.65 [95% CI, 1.60–1.70]), inflammatory heart diseases (1.53 [95% CI, 1.31–1.80]), dysrhythmia (1.44 [95% CI, 1.42–1.46]), and thrombotic disorders (1.42 [95% CI, 1.35–1.48]). The increased risk persisted up to 18 months, with the highest association observed for 1 to 6 months after infection. The risk of cardiovascular diseases was pronounced with COVID-19 severity; however, it decreased with the administration of complete vaccination and subsequent booster doses. A similar risk of cardiovascular outcomes existed across every SARS-CoV-2 era (pre-delta, delta, and omicron). Similar patterns were observed in the validation cohort. The absolute risk of cardiovascular disease events after SARS-CoV-2 infection remained remarkably low (2.12% versus 1.31% in the noninfected population), particularly stroke (0.24% versus 0.13%) and ischemic heart disease (0.73% versus 0.39%). CONCLUSIONS: This binational study observed associations between SARS-CoV-2 infection and cardiovascular events during extended follow-up across viral eras. Complete vaccination was linked to lower cardiovascular events. However, the absolute risk of cardiovascular disease events after SARS-CoV-2 infection remained remarkably low, particularly for stroke and ischemic heart disease. Although these findings suggest ongoing vigilance and preventive measures remain crucial, they should be interpreted within the context of these low absolute risks when considering long-term cardiovascular complications.
- Top Cited PapersOpen Access
- 15 May 2025
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 68 (5) , 329-343
Global burden of asthma among children and adolescents with projections to 2050: a comprehensive review and forecasted modeling study
Understanding pediatric asthma is crucial to its effective diagnosis and intervention, as it may alleviate the adulthood disease burden. This epidemiological review describes the prevalence of asthma among individuals under 20 years of age by categorizing them into 3 age groups: 1–4, 5–9, and 10–19 years. Estimates were obtained from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, which covered the prevalence of asthma from 1990 to 2021 across 21 GBD regions with 95% uncertainty intervals (UIs). We also projected the prevalence of pediatric asthma in 2050 by using a logistic regression predictive model from the existing literature and incorporating body mass index as a covariate with fixed coefficients over time. Overall, a continuous decline in asthma prevalence rates among children and adolescents was observed from 1990 to 2021, with higher rates in males and a peak prevalence rate in the 5–9 years group. Central Europe showed significantly increased prevalence rates compared to those of other regions. Our projection suggests that the prevalence rate of pediatric asthma will decline to approximately 2,608.05 per 100,000 population by 2050 (95% UI, 1,632.94–3,868.26), representing a 39.5% decrease from the 2021 figures. Despite these trends, asthma remains a substantial health burden for children and adolescents that may persist into adulthood. Therefore, proactive diagnosis and intervention are essential to mitigating the associated disease burden.
- 15 May 2025
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 68 (5) , 329-343
Top Cited PapersOpen AccessGlobal burden of asthma among children and adolescents with projections to 2050: a comprehensive review and forecasted modeling study
Understanding pediatric asthma is crucial to its effective diagnosis and intervention, as it may alleviate the adulthood disease burden. This epidemiological review describes the prevalence of asthma among individuals under 20 years of age by categorizing them into 3 age groups: 1–4, 5–9, and 10–19 years. Estimates were obtained from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, which covered the prevalence of asthma from 1990 to 2021 across 21 GBD regions with 95% uncertainty intervals (UIs). We also projected the prevalence of pediatric asthma in 2050 by using a logistic regression predictive model from the existing literature and incorporating body mass index as a covariate with fixed coefficients over time. Overall, a continuous decline in asthma prevalence rates among children and adolescents was observed from 1990 to 2021, with higher rates in males and a peak prevalence rate in the 5–9 years group. Central Europe showed significantly increased prevalence rates compared to those of other regions. Our projection suggests that the prevalence rate of pediatric asthma will decline to approximately 2,608.05 per 100,000 population by 2050 (95% UI, 1,632.94–3,868.26), representing a 39.5% decrease from the 2021 figures. Despite these trends, asthma remains a substantial health burden for children and adolescents that may persist into adulthood. Therefore, proactive diagnosis and intervention are essential to mitigating the associated disease burden.
- Top Cited Papers
- 5 May 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (30) , 2991-3002
Live zoster vaccination and cardiovascular outcomes: a nationwide, South Korean study
Background and Aims: Despite the potential association between herpes zoster infection and cardiovascular events, limited studies have investigated the relationship between live zoster vaccination and cardiovascular outcomes. This large-scale, population-based cohort study with a long-term follow-up aimed to investigate the association between live zoster vaccination and the risk of various cardiovascular events. Methods: Data on comprehensive information of individuals aged ≥50 years from South Korea (n = 2 207 784) were included from 1 January 2012, to 31 December 2021. National insurance information from the Korea Health Insurance Review and Assessment Service, the national health examination results from the Korean National Health Insurance Service, and the live zoster vaccination data from the Korea Disease Control and Prevention Agency were merged. The risk of incident cardiovascular outcomes after live zoster vaccination was assessed compared with unvaccinated individuals. The primary outcome was the risk of cardiovascular diseases based on International Classification of Diseases, Tenth Revision code diagnosis. In propensity score–based overlap weighted cohorts, Cox proportional hazard models were used to estimate hazard ratios (HRs) for overall and specific cardiovascular outcomes, while calculating restricted mean survival time (RMST) for each outcome. The observation period was from 1 January 2012, to 31 January 2024. Multiple stratification analyses were performed. Results: After applying propensity score–based overlap weighting, 1 271 922 individuals were included [mean age, 61.3 years (standard deviation, 3.4); 548 986 (43.2%) male; median follow-up time, 6.0 years] in overlap-weighted cohort. Live zoster vaccination was associated with lower risks of overall cardiovascular events [HR 0.77, 95% confidence interval (CI) 0.76–0.78], particularly major adverse cardiovascular events [0.74 (0.71–0.77)], heart failure [0.74 (0.70–0.77)], cerebrovascular disorders [0.76 (0.74–0.78)], ischaemic heart disease [0.78 (0.76–0.80)], thrombotic disorders [0.78 (0.74–0.83)], and dysrhythmia [0.79 (0.77–0.81)]. The RMST difference for overall cardiovascular events following live zoster vaccination was 95.14 days per decade (95% CI 94.99–95.30). The protective association persisted up to 8 years, with the greatest reduction observed 2–3 years post-vaccination. The decrease in cardiovascular disease risk was more pronounced among males, individuals aged <60 years, those with unhealthy lifestyle habits, and those from low-income households and rural residents. Conclusions: These findings suggest that live zoster vaccination may be beneficial as a public health strategy with potential implications for cardiovascular disease burden in the general population. This strategy may help address health disparities and mortality linked to cardiovascular complications.
- 5 May 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (30) , 2991-3002
Top Cited PapersLive zoster vaccination and cardiovascular outcomes: a nationwide, South Korean study
Background and Aims: Despite the potential association between herpes zoster infection and cardiovascular events, limited studies have investigated the relationship between live zoster vaccination and cardiovascular outcomes. This large-scale, population-based cohort study with a long-term follow-up aimed to investigate the association between live zoster vaccination and the risk of various cardiovascular events. Methods: Data on comprehensive information of individuals aged ≥50 years from South Korea (n = 2 207 784) were included from 1 January 2012, to 31 December 2021. National insurance information from the Korea Health Insurance Review and Assessment Service, the national health examination results from the Korean National Health Insurance Service, and the live zoster vaccination data from the Korea Disease Control and Prevention Agency were merged. The risk of incident cardiovascular outcomes after live zoster vaccination was assessed compared with unvaccinated individuals. The primary outcome was the risk of cardiovascular diseases based on International Classification of Diseases, Tenth Revision code diagnosis. In propensity score–based overlap weighted cohorts, Cox proportional hazard models were used to estimate hazard ratios (HRs) for overall and specific cardiovascular outcomes, while calculating restricted mean survival time (RMST) for each outcome. The observation period was from 1 January 2012, to 31 January 2024. Multiple stratification analyses were performed. Results: After applying propensity score–based overlap weighting, 1 271 922 individuals were included [mean age, 61.3 years (standard deviation, 3.4); 548 986 (43.2%) male; median follow-up time, 6.0 years] in overlap-weighted cohort. Live zoster vaccination was associated with lower risks of overall cardiovascular events [HR 0.77, 95% confidence interval (CI) 0.76–0.78], particularly major adverse cardiovascular events [0.74 (0.71–0.77)], heart failure [0.74 (0.70–0.77)], cerebrovascular disorders [0.76 (0.74–0.78)], ischaemic heart disease [0.78 (0.76–0.80)], thrombotic disorders [0.78 (0.74–0.83)], and dysrhythmia [0.79 (0.77–0.81)]. The RMST difference for overall cardiovascular events following live zoster vaccination was 95.14 days per decade (95% CI 94.99–95.30). The protective association persisted up to 8 years, with the greatest reduction observed 2–3 years post-vaccination. The decrease in cardiovascular disease risk was more pronounced among males, individuals aged <60 years, those with unhealthy lifestyle habits, and those from low-income households and rural residents. Conclusions: These findings suggest that live zoster vaccination may be beneficial as a public health strategy with potential implications for cardiovascular disease burden in the general population. This strategy may help address health disparities and mortality linked to cardiovascular complications.
- Top Cited PapersOpen Access
- 18 January 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 80, 103069
Prediction model for type 2 diabetes mellitus and its association with mortality using machine learning in three independent cohorts from South Korea, Japan, and the UK: a model development and validation study
- 18 January 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 80, 103069
Top Cited PapersOpen AccessPrediction model for type 2 diabetes mellitus and its association with mortality using machine learning in three independent cohorts from South Korea, Japan, and the UK: a model development and validation study